Perspectives on RWE: Assessing Its Use, Impact, and Role in the U.S. and EU

The adoption of real-world evidence (RWE) can help ensure the availability of safe, effective and innovative technologies for patients. Demand for RWE continues to grow, with global regulatory bodies looking to Real-World Data (RWD) for pre- and post-market decisions and payers requiring more evidence to make their coverage decisions.

In this virtual session, attendees will learn about the types of RWE, explore the role of technology in advancing device evaluation, understand barriers and facilitators for RWE, and hear how RWE can be used to support patients, as well as regulatory and coverage decisions.


Robbert Zusterzeel, MD, PhD, MPH
NESTcc Data Network Director, MDIC


Daniel Caños, PhD, MPH
FDA CDRH, Office of Clinical Evidence and Analysis, Director

Martin Gibson
CEO, NorthWest EHealth Limited

Bray Patrick-Lake, MFS
Director of Strategic Partnerships, Evidation Health

Justin W. Timbie, PhD
Senior Health Policy Researcher, RAND


Virtual | See the APF Agenda